secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001193125-25-096703
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio director Mark Iwicki to resign from board, effective Dec 31, 2025
-------------------------------------------------------------------------

- Mark Iwicki notified his resignation from the board on April 25, 2025, effective December 31, 2025.
- He will remain Chair and Compensation Committee chair, and Audit Committee member until the effective date.
- Resignation is to reduce board commitments; no disagreement with the company.
- He will continue as CEO of Inhibikase Therapeutics, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525096703/0001193125-25-096703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525096703/d933973d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-096703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer